title: [Use of the preparation Iso Mack Retard 60 mg I 120 mg in the treatment of patients with advanced ischemic heart disease].
abstract: The purpose of the study was an evaluation of the effectiveness of the preparation ISO MACK RETARD in capsules of 60 mg and 120 mg in patients with advanced exacerbated ischaemic heart disease. The study included 72 patients, in 61 (84.7%) of them very good result treatment, estimated subjectively, was achieved. ISO MACK RETARD in capsules of 60 and 120 mg was well tolerated; in the studied group no side effects were observed.
authors.affiliation: Katedry i Kliniki Kardiologii Ak. Med., Lublinie.
authors.forename: M
authors.initials: M
authors.lastname: Markiewicz
authors.forename: A
authors.initials: A
authors.lastname: Jach
authors.forename: A
authors.initials: A
authors.lastname: Wysokiński
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy*
chemical_list: D007548:Isosorbide Dinitrate
vernacular_title: Zastosowanie preparatu ISO MACK Retard 60 mg I 120 mg 2 leczeniu chorych z zaawansowana choroba niedokrwienna serca.